Cannabidiol Gel (Zynerba)

N/A

Report date: 2026/03/10 20:00:16

Base Information

Drug NameCannabidiol Gel (Zynerba)
Drug Alias NameZygelZYN002ZYN-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor inverse agonistsCannabinoid CB1 receptor inverse agonistsSerotonin 5-HT1 receptors modulators +[4] 
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptorSerotonin 5-HT1 receptors +[4] 
Therapy Area/IndicationsFragile X SyndromeDiGeorge Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia +[5] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesZynerba Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesHarmony Biosciences Management IncZynerba Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsFragile X SyndromeDiGeorge Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A